- Price
- $232.85
- Day
- +0.09%
- Mkt Cap
- $22.69B
- 52W Range
- $195.14 – $269.44
- Volume
- 603.7K
- Beta
- 0.91
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
DUBLIN, IRELAND, July 30, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.69 per share. This represents a $0.06 increase in the dividend and the Company's 21st consecutive year of dividend growth. The dividend is payable on September 25, 2026, to shareholders of record at the close of business on September 4, 2026.
Read full article
STE is expected to deliver fiscal first-quarter revenue and EPS growth, driven by strength in Healthcare, continued momentum in AST, and healthy demand in Life Sciences.
Read full article
Steris provides infection prevention products and sterilization services to medical clientele (such as hospitals, outpatient surgery centers, and pharmaceutical companies). Steris has increased its dividend for 21 consecutive years. The 10-year dividend growth rate of 9.6% is strong, but more recent dividend raises have actually been over 10%. STE has a great financial position. Its long-term debt/equity ratio is 0.3, while the interest coverage ratio is over 18.
Read full article
Entropy Technologies LP lessened its position in shares of STERIS plc (NYSE: STE) by 25.6% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 9,899 shares of the medical equipment provider's stock after selling 3,398 shares during the period. Entropy Technologies LP's holdings
Read full article
DUBLIN, IRELAND, July 27, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2027 first quarter results at 9:00 a.m. ET on August 6, 2026. The conference call can be heard live at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc.
Read full article
Arrowstreet Capital Limited Partnership boosted its stake in shares of STERIS plc (NYSE: STE) by 20.6% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 519,511 shares of the medical equipment provider's stock after purchasing an additional 88,872 shares during
Read full article